Physiological and reproductive effects of beta adrenergic receptor antagonists in Daphnia magna

Archives of Environmental Contamination and Toxicology

Volumn 50, Issue 4, 2006, Pages 503-510

  Dzialowski, Edward M ^a   Turner, Philip K ^a   Brooks, Bryan W ^b  

^a UNIVERSITY OF NORTH TEXAS   (United States)

^b BAYLOR UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BIOLOGICAL MARKER; METOPROLOL; PROPRANOLOL DERIVATIVE;

BIOMARKER; BIOTA; DRUG; ECOTOXICOLOGY; FECUNDITY; RISK ASSESSMENT; SUBLETHAL EFFECT; TOXICITY;

ARTICLE; DAPHNIA; ECOTOXICOLOGY; EXPOSURE; FERTILITY; GROWTH; HEART RATE; METABOLIC RATE; MORTALITY; NONHUMAN; PRIORITY JOURNAL; REPRODUCTION; STANDARD; TOXICITY;

ADRENERGIC BETA-ANTAGONISTS; ANIMALS; DAPHNIA; DOSE-RESPONSE RELATIONSHIP, DRUG; REPRODUCTION; TOXICITY TESTS; WATER POLLUTANTS, CHEMICAL;

DAPHNIA; DAPHNIA MAGNA;

EID: 33645578451     PISSN: 00904341     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00244-005-0121-9     Document Type: Article

References (34)

1. Alexander BS, Wood MD (1987) Stereoselective blockade of central [3H]5-hydroxytryptamine binding to multiple sites (5-HT1A, 5-HT1B, and 5-HT1C) by mianserin and propranolol. J Pharm Pharmacol 39:664-666
2. Barata C, Porte C, Baird DJ (2004) Experimental designs to assess endocrine disrupting effects in invertebrates a review. Exotoxicology 13:511-517
3. Baylor ER (1942) Cardiac pharmacology of the cladoceran, Daphnia. Biol Bull 83:165-172
4. Bekker JM, Krijgsman BJ (1951) Physiological investigations into the heart function of Daphnia. J Physiol 115:249-257
5. Belfroid A, Van der Horst A, Vethaak A, Schafer A, Rijis G, Wegener J, Cofino W (1999) Analysis and occurrence of estrogenic hormones and their conjugates in surface water and waste water in the Netherlands. Sci Total Env 225:101-108
6. Brooks BW, Foran CM, Richards SM, Weston JJ, Turner PK, Stanley JK, Solomon KR, Slattery M, La Point TW (2003) Aquatic ecotoxicology of fluoxetine. Toxicol Lett 142:169-183
7. Campbell AK, Wann KT, Matthews SB (2004) Lactose causes heart arrhythmia in the water flea Daphnia pulex. Comp Biochem Physiol B 139:225-234
8. Cleuvers M (2005) Initial risk assessment for three β-blockers found in aquatic environments. Chemosphere 59:199-205
9. Daughton CG, Ternes TA (1999) Pharmaceuticals and personal care products in the environment: agents of subtle change? Environ Health Perspect 107:(Suppl 6)907-938
10. Federal Register (1995) Final water quality guidance for the Great Lakes system; Final rule. 40 CFR 9, 122, 123, 131 and 132. Vol. 6, No. 56, 15366-15425
11. Ferrari B, Mons R, Vollat B, Fraysse B, Paxeus N, Lo Giudice R, Pollio A, Garric J (2004) Environmental risk assessment of six human pharmaceuticals: are the current environmental risk assessment procedures sufficient for the protection of the aquatic environment? Environ Toxicol Chem 23:1344-1354
12. Goodwin GM, Green AR (1985) A behavioural and biochemical study in mice and rats of putative selective agonists and antagonists for 5-HT1 and 5-HT2 receptors. Br J Pharmacol 84:743-753
13. Hemming JM, Turner PK, Brooks BW, Waller WT, La Point TW (2002) Assessment of toxicity reduction in wastewater effluent flowing through a treatment wetland using Himephales promelas, Ceriodaphnia dubia, and Vibrio fischeri. Arch Environ Contam Toxicol 42:9-16
14. Hoffman BB (2001) Catecholamines, sympathiomimetic drugs, and adrenergic receptor antagonists. In: Hardman Limbird JG. LE, Goodman A, Gilman. (eds) Goodman & Gilman's the pharmacological basis of therapeutics 10 ed. McGraw-HillNew York215268
15. Huggett DB, Brooks BW, Peterson B, Foran CM, Schlenk D (2002) Toxicity of select beta adrenergic receptor-blocking pharmaceuticals (β-blockers) on aquatic organisms. Arch Environ Contam Toxicol 43:229-235
16. Huggett DB, Foran CM, Brooks BW, Weston W, Peterson B, Marsh KE, La Point TW, Schlenk D (2003a) Comparison of in vitro and in vivo bioassays for estrogenicity in effluent from North American municipal wastewater facilities. Toxicol Sci 72:77-83
17. Huggett DB, Khan I, Allgood J, Foran C, Schlenk D (2003b) Determination of beta-adrenergic receptor blocking pharmaceuticals in United States wastewater effluent. Environ Poll 121:199-205
18. Huggett DB, Cook JC, Erickson JE, Williams RT (2003c) Theoretical model for prioritizing potential impacts of human pharmaceuticals to fish. Human Ecol Risk Assess 9:1789-1799
19. Kim H, Jeong K, Lee S, Jung S (2003) Molecular modeling of the chiral recognition of propranolol enantiomers by a β-cyclodextrin. Bull Korean Chem Soc 24:95-98
20. Knops M, Altenburger R, Segner H (2001) Alterations of physiological energetics, growth, and reproduction of Daphnia magna under toxicant stress. Aquatic Toxicol 53:79-90
21. Kolpin DW, Furlong ET, Meyer MT, Thurman EM, Zaugg SD, Barber LB, Buxton HT (2002) Pharmaceuticals, hormones, and other organic wastewater contaminants in U.S. streams, 1999-2000: a national reconnaissance. Envrion Sci Technol 36:1202-1211
22. Kozak RI, Haese D, Verstraete W (2001) Pharmaceuticals in the environment: focus on 17-alpha ethinylestradiol. In: Kummerer K (ed) Pharmaceuticals in the environmentSpringer-VerlagHeidelberg4965
23. Maynard DM (1960) Circulation and heart function. In: Waterman TH, (ed) The physiology of Crustacea. Academic Press, New York, pp 161-226
24. National Center for Health Statistics (2004) Health, United States, 2004; With Chartbook on Trends in the Health of Americans. pp. 513 Hyattsville, Maryland
25. Pirow R, Wollinger F, Paul RJ (1999) The sites of respiratory gas exchange in the planktonic crustacean Daphnia magna: an in vivo study employing blood haemoglobin as an internal oxygen probe. J Exp Biol 202:3089-3099
26. Pirow R, Bäumer C, Paul RJ (2001) Benefits of haemoglobin in the cladoceran crustacean Daphnia magna. J Exp Biol 204:3425-3441
27. Postmes TJ, Prick R, Borens I (1989) The deceleration of the heart frequency in the waterflea Daphnia magna by adrenoceptor agonists and antagonists. Hydrobiologia 171:141-148
28. Spicer JI (2001) Development of cardiac function in crustaceans: patterns and processes. Am Zool 41:1068-1077
29. Spicer JI, El-Gamal MM (1999) Hypoxia accelerates the development of respiratory regulation in brine shrimp, but at a cost. J Exp Biol 202:3637-3646
30. Taylor EW, Jordan D, Coote JH (1999) Central control of the cardiovascular and respiratory systems and their interactions in vertebrates. Physiol Rev 79:855-916
31. Ternes T (1998) Occurrence of drugs in German sewage treatment plants and rivers. Water Res 32:3245-3260
32. USEPA (1994) 10-day Chronic Toxicity Test using Daphnia Magna or Daphnia Pulex. SOP #2028. Environmental Response Team. Compendium of ERT Standard Operating Protocols. Office of Solid Waste and Emergency Response, U.S. Environmental Protection Agency, Edison, NJ
33. Villegas-Navarro A, Rosas-L E, Reyes JL (2003) The heart Daphnia magna: effects of four cardioactive drugs. Comp Biochem Physiol C 136:127-134
34. Wilkens JL (1995) Regulation of the cardiovascular system in crayfish. Am Zool 35:37-48